Amneal製藥 AMRX 深 滬
等待開盤 04-02 09:30:00 美东时间
12.71
+0.280
+2.25%
華盛通- 最 高12.725
- 今 開12.55
- 成交量 180.88万股
- 最 低 12.5025
- 昨 收 12.43
- 總市值 40.54亿
- 52周最高 15.42
- 市盈率 靜 57.30
- 換手率 0.57%
- 52周最低 7.01
- 委 比 -84.92%
- 總股本 3.19亿
- 歷史最高 24.48
- 量 比 1.37
- 振 幅 1.79%
- 歷史最低 1.24
- 每 手 1
- 風險率 2.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Amneal to Participate in Upcoming Investor Conference
Amneal Pharmaceuticals announced that Chirag Patel will participate in the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, in Miami, FL. A webcast will be available on Amneal’s Investor Relations website. Amneal, headquartered in Bridgewater, NJ, is a global biopharmaceutical company offering affordable and innovative medicines. For more information, visit their website or contact Anthony DiMeo.
03-05 21:05
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Truist Securities Maintains Buy on Amneal Pharmaceuticals, Raises Price Target to $17
Truist Securities analyst Les Sulewski maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Buy and raises the price target from $15 to $17.
03-02 21:44
Generic Drugs Focused Amneal Pharmaceuticals Revenue Crosses $800 Million
Amneal beats fourth-quarter earnings and revenue estimates, driven by CREXONT sales, and guides up to $1.03 in 2026 earnings.
02-27 22:17
Earnings Scheduled For February 27, 2026
Companies Reporting Before The Bell • Escalade (NASDAQ:ESCA) is estimated to re...
02-27 19:11
Amneal Pharmaceuticals Q4 Earnings Summary & Key Takeaways
The Q4 earnings report for Amneal Pharmaceuticals (NASDAQ:AMRX) was released on...
02-27 19:02
Amneal Pharmaceuticals Sees FY2026 Adj EPS $0.93-$1.03 vs $0.94 Est; Sees Sales $3.050B-$3.150B vs $3.210B Est
Amneal Pharmaceuticals (NASDAQ:AMRX) is looking for FY2026 Adj EPS of $0.93-$1.03 vs $0.94 analyst estimate. sees sales of $3.050 billion-$3.150 billion vs $3.210 billion analyst estimate.
02-27 19:01
Amneal Pharmaceuticals Q4 Adj. EPS $0.21 Beats $0.18 Estimate, Sales $814.319M Beat $807.895M Estimate
Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.18 by 13.51 percent. This is a 75 percent increase over earnings of $0.12 per share from
02-27 19:00
Earnings Outlook For Amneal Pharmaceuticals
Amneal Pharmaceuticals (NASDAQ:AMRX) will release its quarterly earnings report...
02-26 22:01
